vs
Side-by-side financial comparison of Evolent Health, Inc. (EVH) and International General Insurance Holdings Ltd. (IGIC). Click either name above to swap in a different company.
Evolent Health, Inc. is the larger business by last-quarter revenue ($496.2M vs $403.8M, roughly 1.2× International General Insurance Holdings Ltd.). International General Insurance Holdings Ltd. runs the higher net margin — 26.0% vs -5.4%, a 31.4% gap on every dollar of revenue.
Magellan Health Inc., is an American for-profit managed health care company and subsidiary of Centene that focuses on special populations and other specialty areas of healthcare. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. It ranked 390 on the Fortune 500 in 2021.
China Taiping Insurance Holdings Company Limited (CTIH) formerly China Insurance International Holdings Company Limited (CIIH), is a Chinese insurance conglomerate. The company has strong Chinese Central Government background despite being incorporated in Hong Kong. It is considered as a red chip company.
EVH vs IGIC — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $496.2M | $403.8M |
| Net Profit | $-26.6M | $105.1M |
| Gross Margin | 16.9% | — |
| Operating Margin | — | — |
| Net Margin | -5.4% | 26.0% |
| Revenue YoY | 2.6% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | — | $2.31 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $496.2M | — | ||
| Q4 25 | $468.7M | — | ||
| Q3 25 | $479.5M | $403.8M | ||
| Q2 25 | $444.3M | $261.9M | ||
| Q1 25 | $483.6M | — | ||
| Q4 24 | $646.5M | — | ||
| Q3 24 | $621.4M | $369.6M | ||
| Q2 24 | $647.1M | $265.8M |
| Q1 26 | $-26.6M | — | ||
| Q4 25 | $-429.1M | — | ||
| Q3 25 | $-20.9M | $105.1M | ||
| Q2 25 | $-19.9M | $61.4M | ||
| Q1 25 | $-64.6M | — | ||
| Q4 24 | $-22.8M | — | ||
| Q3 24 | $-23.1M | $-134.4M | ||
| Q2 24 | $1.6M | $70.7M |
| Q1 26 | 16.9% | — | ||
| Q4 25 | 20.7% | — | ||
| Q3 25 | 20.8% | — | ||
| Q2 25 | 22.6% | — | ||
| Q1 25 | 21.2% | — | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 13.0% | — | ||
| Q2 24 | 16.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | -87.1% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | -0.3% | 24.2% | ||
| Q1 25 | -0.3% | — | ||
| Q4 24 | -2.9% | — | ||
| Q3 24 | -2.6% | — | ||
| Q2 24 | 1.2% | -73.3% |
| Q1 26 | -5.4% | — | ||
| Q4 25 | -91.6% | — | ||
| Q3 25 | -4.4% | 26.0% | ||
| Q2 25 | -4.5% | 23.5% | ||
| Q1 25 | -13.4% | — | ||
| Q4 24 | -3.5% | — | ||
| Q3 24 | -3.7% | -36.4% | ||
| Q2 24 | 0.2% | 26.6% |
| Q1 26 | — | — | ||
| Q4 25 | $-3.76 | — | ||
| Q3 25 | $-0.24 | $2.31 | ||
| Q2 25 | $-0.44 | $1.36 | ||
| Q1 25 | $-0.63 | — | ||
| Q4 24 | $-0.26 | — | ||
| Q3 24 | $-0.27 | $1.82 | ||
| Q2 24 | $-0.06 | $1.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $142.0M | $244.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $396.4M | $654.8M |
| Total Assets | $1.9B | $2.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $142.0M | — | ||
| Q4 25 | $151.9M | — | ||
| Q3 25 | $116.7M | $244.7M | ||
| Q2 25 | $151.0M | $164.8M | ||
| Q1 25 | $246.5M | — | ||
| Q4 24 | $104.2M | — | ||
| Q3 24 | $96.6M | $219.2M | ||
| Q2 24 | $101.3M | $237.3M |
| Q1 26 | $396.4M | — | ||
| Q4 25 | $415.2M | — | ||
| Q3 25 | $842.2M | $654.8M | ||
| Q2 25 | $896.0M | $662.3M | ||
| Q1 25 | $935.5M | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.0B | $540.5M | ||
| Q2 24 | $1.1B | $588.2M |
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.9B | — | ||
| Q3 25 | $2.5B | $2.0B | ||
| Q2 25 | $2.5B | $2.1B | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | $2.5B | — | ||
| Q3 24 | $2.5B | $1.8B | ||
| Q2 24 | $2.5B | $2.0B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EVH
| Performance Suite | $323.3M | 65% |
| Specialty Technology and Services Suite | $80.8M | 16% |
| Administrative Services | $49.6M | 10% |
| Cases | $42.6M | 9% |
IGIC
Segment breakdown not available.
